It was overexpressed in pancreatic ductal adenocarcinoma (PDAC) and conferred resistance to etoposide (a topoisomerase II inhibitor) in PDAC cells via the downregulation of the BH3-only protein NOXA 43. Here, RTL10 is linked to pancreatic ductal adenocarcinoma.